Navigating systemic therapy for metastatic castration-na ïve prostate cancer

ConclusionThe introduction of potent systemic therapy earlier in the mCNPC disease course has resulted in dramatic improvements in clinical outcomes for patients. As the management of mCNPC continues to evolve, the future remains promising, with the expectation of ongoing improvements to patient outcomes and quality of life.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research